Author:
Xiao Lingfei,Liu Huifan,Wu Shujuan,Huang Huayi,Xie Yuanlong,Wei Renxiong,Lei Jun,Lei Yifeng,Xue Longjian,Yan Feifei,Geng Zhen,Cai Lin
Funder
Program of Excellent Doctoral (Postdoctoral) of Zhongnan Hospital of Wuhan University
Fundamental Research Funds for Central Universities of the Central South University
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference77 articles.
1. Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393:364.
2. Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med. 2007;357:905.
3. Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS, Dell RM, Adams AL. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med. 2020;383:743.
4. Si L, Winzenberg TM, Jiang Q, Chen M, Palmer AJ. Projection of osteoporosis-related fractures and costs in China: 2010–2050. Osteoporos Int. 1929;2015:26.
5. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726.